COLUMBUS, Ohio--(EON: Enhanced Online News)--Leading software and services company Signet Accel announced today that Dr. Peter Embi has been appointed to its executive team as Chief Medical Officer (CMO). As one of the company’s co-founders and creators of its flagship product Avec®, a federated data integration platform, Dr. Embi will add his expertise to the executive team as a practicing physician, researcher and informaticist. His areas of focus include platform strategy, design and development, thought leadership and relationship-building with hospitals, research organizations and professional societies.
“He provides insight into the needs of physicians and researchers working on the frontlines of medicine each day, while possessing the technical knowledge to help our team address those needs. Dr. Embi’s appointment to our executive team is another step forward in the advancement and expansion of our company.”
“My career sits at the intersection of healthcare, informatics and biomedical research. It enables me to draw connections between the real-world issues we face in healthcare and improving health, and the technology solutions needed to address them,” Dr. Embi said. “As Chief Medical Officer, I will work across the organization to ensure our technologies address the driving issues and challenges of both researchers and physicians.”
Dr. Embi approaches healthcare information technology through the lens of clinical data and research. A leader in medicine, academia and business, he is also president and CEO of the Regenstrief Institute, an independent healthcare research institute and support organization to the Indiana University School of Medicine. The CMO position will be a dual role for Dr. Embi.
“Dr. Embi identifies as a physician first, and his patient-centered approach to informatics, research and HIT is in perfect alignment with our mission,” said John Raden, Signet Accel CEO. “He provides insight into the needs of physicians and researchers working on the frontlines of medicine each day, while possessing the technical knowledge to help our team address those needs. Dr. Embi’s appointment to our executive team is another step forward in the advancement and expansion of our company.”
Avec connects disparate databases across healthcare verticals, allowing researchers to identify patterns and trends over a large patient population and offering comprehensive insight into both research and patient treatment. Robust repositories of connected data are a key resource in realizing the promise of precision medicine, a research effort aimed at improving health and treating disease by accounting for patients’ individual differences.
As a software and services company specializing in data integration, Signet Accel brings true interoperability to healthcare data and increases speed of discovery to translational medicine.
About Signet Accel
Signet Accel’s Avec® platform is true interoperability realized in healthcare. As the sole alternative to traditional, centralized data management solutions, Avec® delivers the industry's only purpose-built commercial federated data integration platform, developed and refined over 12 years at The Ohio State University. Signet Accel’s software products and services power the work of consortia, institutions, and health professionals around the world with unmatched security, sharing capability and speed of discovery — advancing academic research, achieving meaningful use objectives, and enabling the continuum of care. Learn how to make your data meaningful and achieve true interoperability at SignetAccel.com.